News summary
Traded: Venture Capital 🦄 on Instagram: "San Francisco-based Remedy Robotics, a healthcare and physical AI company developing robotic systems for cardiovascular and endovascular procedures, raised $62 million in Series B funding in a round led by DCVC, with participation from UC Investments, Skip Capital, Hostplus, Build Collective by Tony Fadell, Blackbird, Divergent Capital and KdT Ventures. Co-founded by CEO Dr. David Bell and CTO Jake Sganga, the company develops the N1 System, an AI-enabled robotic platform designed to support remote, on-site and autonomous vascular procedures. Remedy Robotics will use the funding to accelerate a pivotal clinical trial with the University of California, advance toward FDA approval for neurovascular intervention, deploy prototype N1 Systems across its clinical partner network and further develop its AI and autonomous capabilities. FOUNDERS: Dr. David Bell & Jake Sganga INVESTORS: DCVC, UC Investments, Skip Capital, Hostplus, Build Collective by Tony Fadell, Blackbird, Divergent Capital, KdT Ventures ROUND: Series B AMOUNT: $62,000,000 HQ: San Francisco, California #VentureCapital #RemedyRobotics #DrDavidBell #JakeSganga #TradedVC"
Source: traderVC • Published: 16 Nov 2026, 20:58